Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）

Clinical trial NCT05167994 · RECRUITING

Trial details

NCT number: NCT05167994
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma,Soft Tissue Extremity Trunk Anlotinib Intensity-modulated Radiotherapy Major Wound Complications

Start date: 2020-05-01
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.